Biochemical parameters of cerebral lesions in carotid artery surgery (literature review)
AbstractCurrently, biochemical markers occupy an important position in diagnosis and treatment of a series of diseases and conditions such as myocardial infarction (troponines I and T), oncological diseases (prostate-specific antigen, carcinoembryonic antigen, and others) etc. Brain damage markers have long been investigated in patients with endured strokes, transitory ischemic attacks, as well as with a history of dyscirculatory lesions of the brain and other cerebral diseases. For patients after surgical interventions on the carotid basin, there are no precisely developed markers of controlling the lesion at the serological level, thus making it necessary to consider possible parameters to assess brain damage.
This article reviews the Russian and foreign literature dedicated to biochemical markers of cerebral tissue lesions associated with interventions on carotid arteries, providing general characteristics of the parameters regarded as factors related to cerebral cell lesions, and selecting those more suitable for assessment of namely cerebral damage, such as neuron-specific enolase (NSE), protein S-100B, brain-derived neurotrophic factor (BDNF).
Markers associated with vascular damage or inflammation should be regarded only in conjunction with main proteins of cerebral lesion or neurovisualization. It should be underlined that there are no markers with 100% specificity to nervous tissue damage, and any of the represented indicators may be higher than reference values in one or another condition or disease.
This is followed by describing various clinical situations of their application, such as the use of a temporary shunt in carotid endarterectomy, assessment of postoperative neurological deficit, cerebral hyperperfusion syndrome, intraoperative control, comparing their alterations during stenting of carotid arteries and carotid endarterectomy. Also discussed are possibilities of their use for diagnosis of various changes in the neurological status of patients in the early and remote postoperative period, relationship of these markers with various types and techniques of interventions on carotid arteries. A conclusion was drawn regarding their use in clinical practice.
Funding. The article was prepared under the grant of the President of the Russian Federation No. MD-922.2022.3.
Conflict of interest. The author declares no conflict of interest.
For citation: Kalinin R.E., Pshennikov A.S., Zorin R.A., Suchkov I.A., Solyanik N.A. Biochemical parameters of cerebral lesions in carotid artery surgery (literature review). Angiology and Vascular Surgery. 2022; 28 (1): 148–53. DOI: https://doi.org/10.33029/1027-6661-2022-28-1-148-153 (in Russian)
Keywords:brain damage markers; neuron-specific enolase (NSE); protein S-100B; brain-derived neurotrophic factor (BDNF); carotid endarterectomy; von Willebrand factor
Литература/References
1. Покровский А.В., Головюк А.Л. Состояние сосудистой хирургии в России в 2018 году. М. 2019; 49. [Pokrovsky AV, Golovyk AL. The state of vascular surgery in Russia in 2018. M. 2019; 49. (In Russ.)]
2. Wang KKW, Zhang Z, Kobeissy FH. Biomarkers of brain injury and neurological disorders (1st ed.). Boca Raton: CRC Press. 2004; 650. doi: 10.1201/b17644
3. Korfias S, Papadimitriou A, Stranjalis G, et al. Serum biochemical markers of brain injury. Mini Rev Med Chem. 2009; 9 (2): 227–234. doi: 10.2174/138955709787315994
4. Persson L, Hårdemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987; 18 (5): 911–918. doi: 10.1161/01.str.18.5.911
5. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997; 28 (10): 1956–1960. doi: 10.1161/01.str.28.10.1956
6. Barone FC, Clark RK, Price WJ, et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993; 623 (1): 77–82. doi: 10.1016/0006-8993(93)90012-c
7. Бабаян Г.Б., Зорин Р.А., Пшенников А.С. и др. Предикторы неврологического дефицита при гемодинамически значимых стенозах сонных и позвоночных артерий. Наука молодых (Eruditio Juvenium). 2019; 7 (4): 533–540. [Babayan GB, Zorin RA, Pshennikov AS, et al. Predictors of neurological deficits in patients with hemodynamically significant stenosis. Nauka molodykh (Eruditio Juvenium). 2019; 7 (4): 533–540. (In Russ.)] doi: 10.23888/HMJ201974533-540
8. Malcolm W, Schofield E. Biomarkers for brain disorders. Therapy. 2010; 7 (4): 321–336.
9. Adhiyaman V, Alexander S. Cerebral hyperperfusion syndrome following carotid endarterectomy. J Association Physicians. 2007; 100 (4): 239–244. doi: 10.1093/qjmed/hcm009
10. Крайник В.М., Козлов С.П. Острые реперфузионные повреждения центральной нервной системы при операциях на внутренних сонных артериях. Вестник анестезиологии и реаниматологии. 2011; 8 (2): 49–57. [Kraynik VM, Kozlov SP. Acute reperfusion injuries of the central nervous system during operations on the internal carotid arteries. Bulletin of anesthesiology and resuscitation. 2011; 8 (2): 49–57. (In Russ.)]
11. Heyer EJ, Sharma R, Rampersad A, et al. A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol. 2002; 59 (2): 217–222.
12. Lloyd AJ, Smith JL, Loftus IM, et al. Vascular Surgical Society of Great Britain and Ireland: impact of spontaneous embolization on cognitive function. Br J Surg. 1999; 86: 691.
13. Ogasawara K, Yamadate K, Kobayashi M, et al. Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. J Neurosurg. 2005; 102 (1): 38–44. doi: 10.3171/jns.2005.102.1.0038
14. Mussack T, Biberthaler P, Geisenberger T, et al. Assessment of early brain damage in carotid endarterectomy: evaluation of S-100B serum levels and somatosensory evoked potentials in a pilot study. World J Surg. 2002; 26 (10): 1251–1255. doi: 10.1007/s00268-002-6547-6
15. Falkensammer J, Oldenburg WA, Hendrzak AJ, et al. Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy. Ann Vasc Surg. 2008; 22 (4): 497–504. doi: 10.1016/j.avsg.2008.01.013
16. Wijeyaratne SM, Collins MA, Barth JH, Gough MJ. Jugular venous neurone specific enolase (NSE) increases following carotid endarterectomy under general, but not local, anaesthesia. Eur J Vasc Endovasc Surg. 2009; 38 (3): 262–266. doi: 10.1016/j.ejvs.2009.05.011
17. Mattusch C, Diederich KW, Schmidt A, et al. Effect of carotid artery stenting on the release of S-100B and neurone-specific enolase. Angiology. 2011; 62 (5): 376–380. doi: 10.1177/0003319710387920
18. Mussack T, Hauser C, Klauss V, et al. Serum S-100B protein levels during and after successful carotid artery stenting or carotid endarterectomy. J Endovasc Ther. 2006; 13 (1): 39–46. doi: 10.1583/05-1656.1
19. Scarcello E, Morrone F, Piro P, et al. Protein S-100B as biochemical marker of brain ischemic damage after treatment of carotid stenosis. Ann Vasc Surg. 2011; 25 (7): 975–978. doi: 10.1016/j.avsg.2011.03.007
20. Serra MP, Boi M, Poddighe L, et al. Resveratrol Regulates BDNF, trkB, PSA-NCAM, and Arc Expression in the Rat Cerebral Cortex after Bilateral Common Carotid Artery Occlusion and Reperfusion. Nutrients. 2019; 11 (5): 1000. doi: 10.3390/nu11051000
21. Wiciński M, Malinowski B, Węclewicz MM, et al. Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism. Biomed Res Int. 2017; 2017: 9202954. doi: 10.1155/2017/9202954
22. Plessers M, Van Herzeele I, Hemelsoet D, et al. Perioperative Embolization Load and S-100β Do Not Predict Cognitive Outcome after Carotid Revascularization. Ann Vasc Surg. 2016; 36: 175–181. doi: 10.1016/j.avsg.2016.02.044
23. Alserr AH, Elwan H, Antonopoulos CN, et al. Using serum s100-β protein as a biomarker for comparing silent brain injury in carotid endarterectomy and carotid artery stenting. Int Angiol. 2019; 38 (2): 136–142. doi: 10.23736/S0392-9590.19.04079-3
24. Brightwell RE, Sherwood RA, Athanasiou T, et al. The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg. 2007; 34 (5): 552–560. doi: 10.1016/j.ejvs.2007.06.016
25. Capoccia L, Speziale F, Gazzetti M, et al. Comparative study on carotid revascularization (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging. J Vasc Surg. 2010; 51 (3): 584–592. doi: 10.1016/j.jvs.2009.10.079
26. Sahlein DH, Heyer EJ, Rampersad A, et al. Failure of intraoperative jugular bulb S-100B and neuron-specific enolase sampling to predict cognitive injury after carotid endarterectomy. Neurosurgery. 2003; 53 (6): 1243–1250. doi: 10.1227/01.neu.0000093493.16850.11
27. Makovec M, Kerin K, Skitek M, et al. Association of biomarker S100B and cerebral oximetry with neurological changes during carotid endarterectomy performed in awake patients. Vasa. 2020; 49 (4): 285–293. doi: 10.1024/0301-1526/a000861
28. Nagy B, Woth G, Mérei Á, et al. Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery. Indian J Med Res. 2016; 143 (2): 220–226. doi: 10.4103/0971-5916.180212
29. Palombo D, Lucertini G, Mambrini S, et al. Subtle cerebral damage after shunting vs non shunting during carotid endarterectomy. Eur J Vasc Endovasc Surg. 2007; 34 (5): 546–551. doi: 10.1016/j.ejvs.2007.05.028
30. Dragas M, Koncar I, Opacic D, et al. Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy. PLoS One. 2015; 10 (4): 124067. doi: 10.1371/journal.pone.0124067